ReSolve completes sale of medi-tech business
ReSolve is delighted to announce the sale of the business of Synapse Electroceutical Limited (Synapse) on 7th January 2020.
Synapse was established in 2003 to develop an innovative wound care product, ‘Accel-Heal’ which was accepted by the NHS in 2015. More recently the company had been seeking to raise funds necessary for investment in its commercial activities. In the absence of further investment, the company’s directors sought alternative options to save the product.
ReSolve completed the sale of the Company’s business and assets out of administration to Dennex Holdings (UK) Limited shortly after their appointment